Vitamin D can prevent COVID-19 infection-induced multiple organ damage

被引:88
作者
Aygun, Hatice [1 ]
机构
[1] Tokat Gaziosmanpasa Univ, Fac Med, Dept Physiol, TR-60030 Tokat, Turkey
关键词
Vitamin D; Covid-19; Cytokine storm; Multiple organ damage; ANGIOTENSIN-CONVERTING-ENZYME; ACE2; EXPRESSION; LUNG INJURY; 1,25-DIHYDROXYVITAMIN-D3; FAILURE; PROTEIN;
D O I
10.1007/s00210-020-01911-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Vitamin D is an immunomodulator hormone with an anti-inflammatory and antimicrobial effect with a high safety profile. A lot of COVID-19 infected patients develop acute respiratory distress syndrome (ARDS), which may lead to multiple organ damage. These symptoms are associated with a cytokine storm syndrome. The aim of this letter is to note the 5 crucial points that vitamin D could have protective and therapeutic effects against COVID-19. For that reason, COVID-19 infection-induced multiple organ damage might be prevented by vitamin D.
引用
收藏
页码:1157 / 1160
页数:4
相关论文
共 43 条
[1]   Role of Wnt4/β-catenin, Ang II/TGFβ, ACE2, NF-κB, and IL-18 in attenuating renal ischemia/reperfusion-induced injury in rats treated with Vit D and pioglitazone [J].
Ali, Rabab M. ;
Al-Shorbagy, Muhammad Y. ;
Helmy, Maged W. ;
El-Abhar, Hanan S. .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 831 :68-76
[3]  
[Anonymous], 2020, FRONT MED
[4]  
[Anonymous], 2020, INDIVIDUAL VARIATION
[5]  
[Anonymous], DECREASE ACE2 MRNA E
[6]  
[Anonymous], 2020, VITAMIN D SUPPLEMENT
[7]   IMMUNOMODULATORY EFFECTS OF 1,25-DIHYDROXYVITAMIN D3 ON TH1/TH2 CYTOKINES IN INFLAMMATORY BOWEL DISEASE: AN IN VITRO STUDY [J].
Ardizzone, S. ;
Cassinotti, A. ;
Trabattoni, D. ;
Manzionna, G. ;
Rainone, V. ;
Bevilacqua, M. ;
Massari, A. ;
Manes, G. ;
Maconi, G. ;
Clerici, M. ;
Porro, G. Bianchi .
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2009, 22 (01) :63-71
[8]  
BENETEAUBURNAT B, 1990, CLIN CHEM, V36, P344
[9]  
Cantorna MT, 2005, J RHEUMATOL, V32, P11
[10]   Ventilator-associated pneumonia [J].
Chastre, J ;
Fagon, JY .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (07) :867-903